Plain-English translation of NCT07276958 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new medication called to see how safe it is and how well people tolerate it. The trial includes three groups: healthy volunteers, people with systemic lupus erythematosus (SLE), and people with rheumatoid arthritis (RA). Over about a year, researchers will give participants different doses of the medication — some as a single injection and others as multiple injections over time — to learn whether this treatment is safe enough to study further.
Lupus and rheumatoid arthritis are serious autoimmune diseases that damage joints and organs, and many people don't respond well to current treatments. This trial is exploring whether this medication could be a new option for people whose disease hasn't improved with other therapies.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive injections of the medication or placebo (a dummy injection with no active drug) at study visits over about a year. Healthy volunteers will receive a single injection, while people with lupus or arthritis may receive either one injection or multiple injections over several weeks. You'll have blood tests, physical exams, and safety check-ins to make sure the medication is tolerated well. Some visits may be in person at a clinic, and the total time commitment extends up to about 52 weeks.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Australia
China